Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade

by Domen Ribnikar, Hadar Goldvaser, Zachary W. Veitch, Alberto Ocana, Arnoud J. Templeton, Boštjan Šeruga, Eitan Amir
Published 2021-05-01

Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.

by Mustafa Al-Mubarak, Ariadna Tibau, Arnoud J Templeton, David W Cescon, Alberto Ocana, Bostjan Seruga, Eitan Amir
Published 2014-01-01

Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma

by Sara García-Alonso, Inés Romero-Pérez, Lucía Gandullo-Sánchez, Luis Chinchilla, Alberto Ocaña, Juan Carlos Montero, Atanasio Pandiella
Published 2021-08-01

Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors

by Ramy R. Saleh, Nicholas Meti, Domen Ribnikar, Hadar Goldvaser, Alberto Ocana, Arnoud J. Templeton, Bostjan Seruga, Eitan Amir
Published 2020-11-01

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia

by Jesús Fuentes-Antrás, Alicia de Luna, Alfonso López de Sá, Alberto Ocaña, José Ángel García-Sáenz, Fernando Moreno
Published 2020-12-01

Mortalidad por Cáncer de Mama. Policlínico 13 de Marzo. 2014-2015

by Caridad Noguera Gárces, Milagro Yamila Román López, Adis Nuvia Varona Acosta, Dalia Ameiller Sanz, Javier Alberto Ocaña Noguera
Published 2016-11-01

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer

by Laura Díaz-Gil, Fara Brasó-Maristany, Claudriana Locatelli, Ariana Centa, Balász Győrffy, Alberto Ocaña, Aleix Prat, Atanasio Pandiella
Published 2021-10-01

Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer

by Cristina Saiz-Ladera, Mariona Baliu-Piqué, Francisco J. Cimas, Aránzazu Manzano, Vanesa García-Barberán, Santiago Cabezas Camarero, Gonzalo Fernández Hinojal, Atanasio Pandiella, Balázs Győrffy, Balázs Győrffy, Balázs Győrffy, David Stewart, Juan J. Cruz-Hernández, Pedro Pérez-Segura, Alberto Ocana, Alberto Ocana
Published 2021-10-01

HGK promotes metastatic dissemination in prostate cancer

by Sara Garcia-Garcia, Maria Rodrigo-Faus, Noelia Fonseca, Sara Manzano, Balázs Győrffy, Alberto Ocaña, Paloma Bragado, Almudena Porras, Alvaro Gutierrez-Uzquiza
Published 2021-06-01

Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer

by Francisco J. Cimas, Enrique Niza, Alberto Juan, María del Mar Noblejas-López, Iván Bravo, Agustín Lara-Sanchez, Carlos Alonso-Moreno, Alberto Ocaña
Published 2020-10-01

Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1

by Francisco J. Cimas, Arancha Manzano, Mariona Baliu-Piqué, Elena García-Gil, Pedro Pérez-Segura, Ádám Nagy, Atanasio Pandiella, Balázs Győrffy, Alberto Ocana
Published 2020-08-01

Genomic Correlates of DNA Damage in Breast Cancer Subtypes

by Esther Cabañas Morafraile, Javier Pérez-Peña, Jesús Fuentes-Antrás, Aránzazu Manzano, Pedro Pérez-Segura, Atanasio Pandiella, Eva M. Galán-Moya, Alberto Ocaña
Published 2021-04-01

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.

by María Del Mar Noblejas-López, Sara Morcillo-García, Cristina Nieto-Jiménez, Miriam Nuncia-Cantarero, Balázs Győrffy, Eva M Galan-Moya, Atanasio Pandiella, Alberto Ocaña
Published 2018-01-01

Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.

by Arnoud J Templeton, Laura Diez Gonzalez, Francisco E Vera-Badillo, Ariadna Tibau, Robyn Goldstein, Boštjan Šeruga, Amirrtha Srikanthan, Atanasio Pandiella, Eitan Amir, Alberto Ocana
Published 2016-01-01

MZ1 co-operates with trastuzumab in HER2 positive breast cancer

by María del Mar Noblejas-López, Cristina Nieto-Jiménez, Eva M. Galán-Moya, David Tebar-García, Juan Carlos Montero, Atanasio Pandiella, Miguel Burgos, Alberto Ocaña
Published 2021-03-01

Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors.

by Sandra Martínez-Canales, Francisco Cifuentes, Miguel López De Rodas Gregorio, Leticia Serrano-Oviedo, Eva María Galán-Moya, Eitan Amir, Atanasio Pandiella, Balázs Győrffy, Alberto Ocaña
Published 2017-01-01

Functioning of autobiographical memory specificity and self-defining memories in people with cancer diagnosis

by Marta Nieto, Beatriz Navarro-Bravo, Beatriz Moreno, Alberto Ocana, Juan Pedro Serrano, Clotilde Boix Gras, Jorge Ricarte, Luz Fernández-Aguilar, Laura Ros, Jose Miguel Latorre
Published 2019-12-01

Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation

by María del Mar Noblejas-López, Mariona Baliu-Piqué, Cristina Nieto-Jiménez, Francisco J. Cimas, Esther C. Morafraile, Atanasio Pandiella, Ángel L. Corbi, Balázs Győrffy, Alberto Ocaña
Published 2021-04-01

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

by María del Mar Noblejas-López, Cristina Nieto-Jimenez, Miguel Burgos, Mónica Gómez-Juárez, Juan Carlos Montero, Azucena Esparís-Ogando, Atanasio Pandiella, Eva M. Galán-Moya, Alberto Ocaña
Published 2019-08-01

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.

by Alberto Ocana, Francisco Vera-Badillo, Mustafa Al-Mubarak, Arnoud J Templeton, Verónica Corrales-Sanchez, Laura Diez-Gonzalez, María D Cuenca-Lopez, Bostjan Seruga, Atanasio Pandiella, Eitan Amir
Published 2014-01-01